title: MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1.
authors.affiliation: Department of Dermatology, The Jikei University School of Medicine 25-8 Nishi-shimbashi 3-chome, Minato-ku, Tokyo, Japan. Electronic address: nobederm@jikei.ac.jp.
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Nobeyama
authors.affiliation: Department of Dermatology, The Jikei University School of Medicine 25-8 Nishi-shimbashi 3-chome, Minato-ku, Tokyo, Japan.
authors.forename: Hidemi
authors.initials: H
authors.lastname: Nakagawa
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism*; D018899:CpG Islands; D019175:DNA Methylation; D006801:Humans; D053208:Kaplan-Meier Estimate; D008745:Methylation; D009363:Neoplasm Proteins / Q000378:metabolism*; D018317:Nerve Sheath Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D009455:Neurofibroma / Q000175:diagnosis* / Q000378:metabolism; D009456:Neurofibromatosis 1 / Q000175:diagnosis* / Q000378:metabolism; D011379:Prognosis; D012333:RNA, Messenger / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000951:Antigens, Neoplasm; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins; D012333:RNA, Messenger